Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.73 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | KDM4A | O75164 | 4/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13169236 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL8083779 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL231640 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL1892890 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL7942101 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL235238 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL8087077 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL8083762 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL35856 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 | |
| SCHEMBL1730287 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRDNM1SIGMAR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1934234-B1 | NOVEL AMINE-BORANE COMPOUNDS AND USES THEREOF | YISSUM RES DEV CO (IL) | 2011-11-30 | — | — | EP | claimed |
| US-20250019836-A1 | TREATMENT LIQUID, TREATMENT METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2025-01-16 | — | — | US | disclosed |
| WO-2023189353-A1 | TREATMENT LIQUID, TREATMENT METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | 富士フイルム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20100284914-A1 | Novel Amine-Borane Compounds and Uses Thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2010-11-11 | — | — | US | disclosed |
| US-20090131366-A1 | Use of Amine-Borane Compounds as Anti-Microbial Agents | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. (IL) | 2009-05-21 | — | — | US | disclosed |
| EP-0519406-B1 | Magnetic recording media using perfluoropolyether derivatives as lubricants | SONY CORP (JP) | 2000-10-25 | — | — | EP | disclosed |
| US-5536425-A | DURABILITY | SONY CORPORATION (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5453539-A | Durability | SONY CORPORATION (JP) | 1995-09-26 | — | — | US | disclosed |
| EP-0519406-A2 | Novel perfluoropolyether derivatives, and lubricants and magnetic recording medium using the same | SONY CORPORATION (JP) | 1992-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131366-A1 | Use of Amine-Borane Compounds as Anti-Microbial Agents | BCAT2, BCAT1, ARG1 | ALDH1A1 3639/4885TSHR 2627/4885DNM1 2204/4885 |
| US-20100284914-A1 | Novel Amine-Borane Compounds and Uses Thereof | SLC1A5, BDKRB1, PAICS | ALDH1A1 3757/4885TSHR 1109/4885DNM1 2564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.